http://www.free-press-release-center.info Latest press releases for zangani from the Free Press Release Center http://www.free-press-release-center.info/pr00000000000000003248.html We have begun a movement to investigate the possibility of changing, or repealing entirely, the Sarbanes-Oxley Act of 2002. Please see link below for open letter and a signed petition that is growing by the minute. The Open Letter: http://www.zangani.com/sox The "Digg" submission http://www.digg.com/business_finance/Sarbanes_Oxley_Could_Be_A_Thing_of_the_Past_Open_Letter_to_Congress http://www.free-press-release-center.info/pr00000000000000001033.html Zangani Investor Community announces Bio Korea 2006 in Seoul on September 6th-8th, 2006 http://www.free-press-release-center.info/pr00000000000000000826.html Interview Available on Zangani Website and Via Podcast http://www.free-press-release-center.info/pr00000000000000000812.html ViRexx Medical Corp. (TSX:VIR - News; AMEX:REX - News), a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, today announced that it has entered into a research collaboration with Defence Research and Development Canada - Suffield (DRDC Suffield) to carry out research on applying ViRexx's proprietary Chimigen(TM) vaccine platform for biodefense. http://www.free-press-release-center.info/pr00000000000000000811.html Zangani Investor Community, an outsourced IR and Business Development firm specializing in small cap and micro cap companies announced today that it interviewed Marc Canton, President of ViRexx Medical Corporation (TSX:VIR; AMEX:REX), on March 23rd, 2006. Mr. Canton discussed latest stage drug candidates for treatment of ovarian cancer and chronic hepatitis B and C., as well as, the Company’s latest growth strategies and its listing on the AMEX http://www.free-press-release-center.info/pr00000000000000000808.html Biophan-Europe to Enter into Negotiations for a Joint R&D Agreement with Siemens Medical Solutions MRI Division